Anbio Biotechnology Class A
(NASDAQ: NNNN)
Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.
22.000 -
+2.710
(+14.05%)
Range
19.310 - 24.000
(24.29%)
Open
19.310
Previous Close
19.290
Bid Price
21.560
Bid Volume
100
Ask Price
23.600
Ask Volume
70
Volume
51,866
Value
695,741
Remark
-
Delayed prices. Updated at 30 Jan 2026 03:11.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
